Case number IPR2017-01526
Mylan Pharmaceuticals Inc., v. Sanofi Aventis Deutschland GmbH > Documents
| Date Field | Doc. No. | Party | Description |
|---|---|---|---|
| Nov 6, 2020 | 100 | petitioner | Petitioner's Mandatory Change-of-Information Notices Download |
| Apr 15, 2020 | 99 | Download | |
| Feb 19, 2020 | 98 | Download | |
| Feb 5, 2020 | 97 | Download | |
| Jan 29, 2020 | 96 | Patent Owner's Motion for Withdrawal of Counsel Download | |
| Jan 8, 2019 | 95 | Order Granting Patent Owner's Motion to Seal Download | |
| Jan 4, 2019 | 94 | Patent Owner Sanofi-Aventis Deutschland GmbH's Notice of Appeal Under 37 C.F.R. 90.2(a) Download | |
| Dec 20, 2018 | 93 | Patent Owner's Motion to Seal Download | |
| Dec 19, 2018 | 91 | Patent Owner's Updated Exhibit List - Public Download | |
| Dec 19, 2018 | 90 | Petitioner's Reply (Redacted Public Version Submitted by Patent Owner) Download | |
| Dec 19, 2018 | 2070 | Expert Declaration of Professor Robert S. Langer in Support of Petition for IPR of Patent Nos. 7,476,652 and 7,713,930 - Public Download | |
| Dec 12, 2018 | 89 | Termination Decision Document Download | |
| Oct 24, 2018 | 87 | Petitioner's Motion to Seal Download | |
| Oct 24, 2018 | 88 | REDACTED - Paper 86 - Mylan Pharmaceutical Inc.'s Sur-Surreply Download | |
| Oct 16, 2018 | 85 | Mylan Pharmaceuticals' Objections Download | |
| Oct 11, 2018 | 84 | Petitioner's Mandatory Change-of-Information Notices Download | |
| Oct 9, 2018 | 78 | Patent Owner's Motion to Seal Download | |
| Oct 9, 2018 | 82 | Patent Owner's Updated Exhibit List Download | |
| Oct 9, 2018 | 80 | Patent Owner's Surreply - Public Download | |
| Oct 9, 2018 | 2062 | Supplemental Declaration of Dr. Bernhardt Trout - Public Download | |
| Oct 9, 2018 | 2064 | Lantus EPAR June 2000 Download | |
| Sep 27, 2018 | 77 | Hearing Transcript Download | |
| Sep 25, 2018 | 75 | Authorizing Sur-reply and Sur-sur-reply Download | |
| Sep 25, 2018 | 76 | Mylan Pharmaceutical Inc.'s Updated Exhibit List Download | |
| Sep 25, 2018 | 1186 | Exhibit 1186A - Final Transcript of Telephonic Conference held September 24, 2018 in IPR-2017-01526 and IPR2017-01528 Download | |
| Sep 24, 2018 | 74 | Mylan Pharmaceutical Inc.'s Updated Exhibit List Download | |
| Sep 24, 2018 | 1186 | RoughtTranscript of Telephone Conference held 09-24-2018 Download | |
| Sep 24, 2018 | 1186 | RoughtTranscript of Telephone Conference held 09-24-2018 Download | |
| Aug 29, 2018 | 73 | Order Adjusting Oral Hearing Time Download | |
| Aug 27, 2018 | 72 | Trial Hearing 37 C.F.R § 42.70 Download | |
| Aug 24, 2018 | 71 | Patent Owner's Reply to Motion to Exclude Download | |
| Aug 24, 2018 | 70 | Mylan Pharmaceutical Inc.'s Reply In Support of Its Motion to Exclude Download | |
| Aug 22, 2018 | 69 | Corrected Paper 57- Mylan_Pharmaceutical's_Request_For_Oral_Argument Download | |
| Aug 21, 2018 | 66 | Mylan Pharmaceutical Inc.'s Motion Requesting Acceptance Download | |
| Aug 21, 2018 | 63 | Patent Owner's Motion Requesting Acceptance of Submission Pursuant to 37 C.F.R. 42.6(b) Download | |
| Aug 21, 2018 | 1184 | Download | |
| Aug 21, 2018 | 1185 | Download | |
| Aug 21, 2018 | 64 | Patent Owner's Opposition to Petitioner's Motion to Exclude Download | |
| Aug 21, 2018 | 65 | Mylan's Updated Exhibit List Download | |
| Aug 21, 2018 | 67 | Mylan Pharmaceutical Inc.'s Opposition to Sanofi's Motion to Exclude Download | |
| Aug 21, 2018 | 68 | Mylan Pharmaceutical Inc.'s Response to Sanofi's Observations on Cross Examination Download | |
| Aug 10, 2018 | 58 | Mylan Pharmaceutical's Request For Oral Argument Download | |
| Aug 10, 2018 | 61 | Patent Owner's Motion to Exclude Download | |
| Aug 10, 2018 | 62 | Patent Owner's Updated Exhibit List Download | |
| Aug 10, 2018 | 57 | Mylan Pharmaceutical's Motion to Exclude Download | |
| Aug 10, 2018 | 60 | Patent Owner's Observations on the Cross Examination of Petitioner's Reply Declarants Download | |
| Aug 10, 2018 | 59 | Patent Owner's Request for Oral Argument Download | |
| Aug 10, 2018 | 2057 | Annex 1, Summary of Product Characteristics Download | |
| Aug 10, 2018 | 2059 | July 30, 2018, Deposition Transcript of Dr. William C. Biggs Download | |
| Aug 10, 2018 | 2061 | August 7, 2018, Deposition Transcript of Dr. Robert S. Langer Download | |
| Aug 10, 2018 | 2056 | S. Simpson & E. Toth, ¿¿¿Expanding the Options in Insulin Therapy: A Review of Insulin Analogues,¿¿¿ 26(3) Canadian Journal of Diabetes, 195-205 (2002) Download | |
| Aug 10, 2018 | 2060 | August 2, 2018, Deposition Transcript of Dr. Robert D. McDuff Download | |
| Aug 10, 2018 | 2058 | July 31, 2018, Deposition Transcript of Dr. Samuel H. Yalkowsky, Volume II Download | |
| Aug 3, 2018 | 56 | Mylan Pharmaceutical Inc.'s Updated Exhibit Download | |
| Jul 30, 2018 | 54 | Mylan Pharmaceuticals' Objections Download | |
| Jul 30, 2018 | 55 | Patent Owner's Notice of Deposition of Dr. Robert S. Langer Download | |
| Jul 27, 2018 | 51 | Patent Owner's Notice of Deposition of Dr. William C. Biggs Download | |
| Jul 27, 2018 | 53 | Mylan Pharmaceuticals Updated Exhibit List Download | |
| Jul 27, 2018 | 52 | Petitioner's Opposition to Patent Owner's Motion to Strike Download | |
| Jul 27, 2018 | 1183 | Transcript of Telephone Conference held on July 26th, 2018, in IPR2017-01526 and IPR2017-01528 Download | |
| Jul 27, 2018 | 1183 | Transcript of Telephone Conference held on July 26th, 2018, in IPR2017-01526 and IPR2017-01528 Download | |
| Jul 26, 2018 | 50 | Patent Owner's Notice of Deposition of Dr. Samuel H. Yalkowsky Download | |
| Jul 24, 2018 | 49 | Patent Owner's Updated Exhibit List Download | |
| Jul 24, 2018 | 48 | Patent Owner's Notice of Deposition of DeForest McDuff, Ph.D. Download | |
| Jul 24, 2018 | 2055 | Transcript of 7/17/2018 Telephonic Conference (IPR2017-01526, IPR2017-01528) Download | |
| Jul 23, 2018 | 46 | Patent Owner Surreply Download | |
| Jul 23, 2018 | 47 | Patent Owner's Motion to Strike Download | |
| Jul 23, 2018 | 2051 | Judge Andrews' Order, Dkt. 287 (Sanofi v. Merck, 16-812-RGA) Download | |
| Jul 23, 2018 | 2052 | Trial Transcript Excerpts (Sanofi v. Merck, 16-812-RGA) Download | |
| Jul 23, 2018 | 2053 | Petitioner's Reply - Public, Redacted Download | |
| Jul 20, 2018 | 45 | Patent Owner's Supplemental Motion to Seal Download | |
| Jul 20, 2018 | 44 | PATENT OWNER¿¿¿S OBJECTIONS TO ADMISSIBILITY OF EVIDENCE SERVED BY PETITIONER MYLAN PHARMACEUTICAL INC. IN INTER PARTES REVIEW Download | |
| Jul 13, 2018 | 41 | Petitioner's Motion To Seal And For Entry Of Proposed Protective Order Download | |
| Jul 13, 2018 | 42 | Mylan Pharmaceutical Inc.'s Updated Exhibit List Download | |
| Jul 13, 2018 | 1130 | Conway-Jacobs, et al., ¿¿¿Isoelectric Focusing in Acrylamide Gels¿¿¿ Use of Amphoteric Dyes As Internal markers For Determination of Isoelectric Points¿¿¿, Analytical BioChem. 43, 394-400 ( 1971) Download | |
| Jul 13, 2018 | 1167 | U.S. Patent No. 6,656,499 (¿¿¿Foldvari¿¿¿) Download | |
| Jul 13, 2018 | 1109 | Sanofi Press Releases 2006 Download | |
| Jul 13, 2018 | 1170 | Pak, et al. ¿¿¿A Simple Apparatus For Measurement of Protein Monofilm Expansion At Air-Water Interface in Response to Soluble Reactants in the Subsolution¿¿¿, J. of Colloid Sci., 16, pp. 513-530 (1961) Download | |
| Jul 13, 2018 | 1110 | Sanofi Press Releases 2005 Download | |
| Jul 13, 2018 | 1162 | Gerhard Wenske, Dictionary of Chemistry German/English (1st ed. 1994) Download | |
| Jul 13, 2018 | 1124 | AU 200072263 A1 (¿¿¿AU ¿¿¿263 application¿¿¿) Download | |
| Jul 13, 2018 | 1132 | Part 2 - A. Martin, et al., ¿¿¿Physical Principles In the Pharmaceutical Sciences¿¿¿ Phys. Pharmacy, Drug Dynamics Inst., Col. Of Pharma., Univ. of Texas, 1983 Download | |
| Jul 13, 2018 | 1169 | Ex. 1169D - Insulin Product Sales Download | |
| Jul 13, 2018 | 1104 | SG Cowen ¿¿¿ Pharmaceutical Therapeutic Categories Outlook, Comprehensive Study (March 2006) Download | |
| Jul 13, 2018 | 1112 | Baynes et al., ¿¿¿Role of Arginine in the Stabilization of Proteins Against Aggregation¿¿¿, Biochemistry, Vol. 44, No. 12, pp. 4919-4925 (2005) Download | |
| Jul 13, 2018 | 1136 | LANGER, Robert S. et al. U.S. Publication No. 2015/0025005A1, Jan. 22, 2015 Download | |
| Jul 13, 2018 | 1142 | LANGER, Robert S. et al. WO2013123492 A1, Aug. 22, 2013 Download | |
| Jul 13, 2018 | 1101 | UBS Equities ¿¿¿ Sanofi-Aventis Q205, Sep. 1, 2005 Download | |
| Jul 13, 2018 | 1143 | 2001 PDR Entry for ¿¿¿Novoline¿¿¿¿¿, pp. 2238-2242 Download | |
| Jul 13, 2018 | 1139 | 2001 PDR Entry for ¿¿¿Etoposide¿¿¿, p. 825 Download | |
| Jul 13, 2018 | 1081 | LANTUS¿¿ About (Current) Download | |
| Jul 13, 2018 | 1119 | CA Patent No. 1,258,427 (¿¿¿CA ¿¿¿427¿¿¿) Download | |
| Jul 13, 2018 | 1179 | Velosulin¿¿ BR Buffered Regular Human Insulin Injection (rDNA origin), Physicians¿¿¿ Desk Reference 56 ed. 2002, pg. 2435 Download | |
| Jul 13, 2018 | 1092 | Cowen and Company, ¿¿¿Therapeutic Categories Outlook¿¿¿, Comprehensive Study (Oct. 2006) Download | |
| Jul 13, 2018 | 1176 | March 2, 2003 Usenet forum post by William Biggs, Preloading Lantus in syringes, misc.health.diabetes, https://groups.google.com/forum/#!msg/misc.health.diabetes/ZNfvSjSwISI/vlNR48z2ME4J Download | |
| Jul 13, 2018 | 1080 | LANTUS¿¿ Home Page (October 2006) Download | |
| Jul 13, 2018 | 1169 | Ex. 1169D - Insulin Product Sales Download | |
| Jul 13, 2018 | 1169 | Ex. 1169D - Insulin Product Sales Download | |
| Jul 13, 2018 | 1180 | Novolin¿¿ R Regular, Human Insulin Injection (recombinant DNA origin), Physicians¿¿¿ Desk Reference 56 ed. 2002, pg. 2423 Download | |
| Jul 13, 2018 | 1087 | FDA Approval Letter ¿¿¿ LANTUS¿¿ Reformulation March 2005 Download | |
| Jul 13, 2018 | 1125 | AU 200072263 A1 (¿¿¿AU ¿¿¿263 application¿¿¿) Download | |
| Jul 13, 2018 | 1121 | Wan, et al., ¿¿¿CMC of Polysorbates¿¿¿, J. of Pharma. Sciences, Vol. 63, No. 1, pp. 136-137 (Jan. 1974) Download | |
| Jul 13, 2018 | 1129 | Safety Alerts Internet Archive ¿¿¿Walgreen Co. Recalls Lantus Insulin Glargine (rDNA origin) Injection¿¿¿ (Nov. 15, 2001) Download | |
| Jul 13, 2018 | 1113 | Baynes et al., ¿¿¿Rational Design of Solution Additives for the Prevention of Protein Aggregation¿¿¿, Biophysical J., Vol. 87, pp.1631-1639 (Sept. 2004) Download | |
| Jul 13, 2018 | 1111 | 1111A - Curriculum Vitae of Professor Robert Langer Download | |
| Jul 13, 2018 | 1127 | U.S. Patent No. 6,211,144 (¿¿¿Havelund¿¿¿) Download | |
| Jul 13, 2018 | 1084 | LANTUS¿¿ - Home Page (Current) Download | |
| Jul 13, 2018 | 1094 | CDC, ¿¿¿About Diabetes¿¿¿, June 1, 2017, (http://www.cdc.gov/biabetes/data) Download | |
| Jul 13, 2018 | 1128 | U.S. Patent No. 6,335,316 (¿¿¿Hughes¿¿¿) Download | |
| Jul 13, 2018 | 1105 | SG Cowen ¿¿¿ Pharmaceutical Therapeutic Categories Outlook, Comprehensive Study (Oct. 2005) Download | |
| Jul 13, 2018 | 1122 | WO 00/23098 (¿¿¿¿¿¿098 application¿¿¿) Download | |
| Jul 13, 2018 | 1171 | U.S. Patent No. 6,100,376 (¿¿¿the ¿¿¿376 patent¿¿¿) Download | |
| Jul 13, 2018 | 1118 | WO 83/00288 A1 (¿¿¿¿¿¿288 application¿¿¿) Download | |
| Jul 13, 2018 | 1131 | U.S. Patent No. 6,737,401 (¿¿¿Kim¿¿¿) Download | |
| Jul 13, 2018 | 1133 | Expert Declaration of Mark Lanterman In Support of Petitioner¿¿¿s Reply For Inter Partes Review of U.S. Pat. No. 7,476,652 and 7,713,930 Download | |
| Jul 13, 2018 | 1140 | 2001 PDR Entry for ¿¿¿Limbitrol¿¿¿¿¿, p. 1538 Download | |
| Jul 13, 2018 | 1182 | Vanofor¿¿ Physicians¿¿¿ Desk Reference 56 ed. 2002, pg. 580-581 Download | |
| Jul 13, 2018 | 1083 | LANTUS¿¿ - How to Inject Lantus With a Vial and Syringe Download | |
| Jul 13, 2018 | 1174 | Declaration of William Curtis Biggs Download | |
| Jul 13, 2018 | 1095 | U.S. SEC Form 20-F for Sanofi-Aventis FY 2003 Download | |
| Jul 13, 2018 | 1172 | U.S. Patent No. 5,656,722 (¿¿¿the ¿¿¿722 patent¿¿¿) Download | |
| Jul 13, 2018 | 1166 | U.S. Patent No. 6,306,440 (¿¿¿Backstrom 2001¿¿¿) Download | |
| Jul 13, 2018 | 1169 | Ex. 1169D - Insulin Product Sales Download | |
| Jul 13, 2018 | 1163 | U.S. Patent No. 4,783,441 (¿¿¿Thurow 1998¿¿¿) Download | |
| Jul 13, 2018 | 1097 | ABN AMRO ¿¿¿ Pharmaceutical Market Share Report (Oct. 2001) Download | |
| Jul 13, 2018 | 1082 | LANTUS¿¿ - Your Diabetes Treatment Routine (Current) Download | |
| Jul 13, 2018 | 1116 | Shao, et al. ¿¿¿ ¿¿¿Differential Effects of Anionic, Cationic, Nonionic, and Physiologic Surfactants on the Dissociation, ¿¿-Chymotryptic Degradation, and Enteral Absorption if Insulin Download | |
| Jul 13, 2018 | 1178 | Phys. Desk Ref., ¿¿¿Iletin¿¿ II¿¿¿, 1997, pp. 1507-1509 Download | |
| Jul 13, 2018 | 1117 | Manning et al., ¿¿¿Stability of Protein Pharmaceuticals¿¿¿, Pharm. Research, Vol. 6, No. 11, pp. 903-918 (1989) Download | |
| Jul 13, 2018 | 1169 | Ex. 1169D - Insulin Product Sales Download | |
| Jul 13, 2018 | 1124 | AU 200072263 A1 (¿¿¿AU ¿¿¿263 application¿¿¿) Download | |
| Jul 13, 2018 | 1135 | 1997 PDR Entry for ¿¿¿Humulin¿¿R¿¿¿, pp. 1497-1498 Download | |
| Jul 13, 2018 | 1085 | LANTUS¿¿ - Explore Diabetes Treatment Options (Current) Download | |
| Jul 13, 2018 | 1177 | Phys. Desk Ref., ¿¿¿Iletin¿¿¿¿¿, 1997, pp. 1503-1504 Download | |
| Jul 13, 2018 | 1106 | SG Cowen ¿¿¿Pharmaceutical Therapeutic Categories Outlook, Comprehensive Study (March 2005) Download | |
| Jul 13, 2018 | 1175 | Diabetes Complications and Control Trial (DCCT) (1993) Download | |
| Jul 13, 2018 | 1111 | 1111A - Curriculum Vitae of Professor Robert Langer Download | |
| Jul 13, 2018 | 1089 | FDA ¿¿¿ 25th Orange Book (2005) Download | |
| Jul 13, 2018 | 1165 | U.S. Patent No. 5,518,998 (¿¿¿Backstrom¿¿¿) Download | |
| Jul 13, 2018 | 1169 | Ex. 1169D - Insulin Product Sales Download | |
| Jul 13, 2018 | 1174 | Declaration of William Curtis Biggs Download | |
| Jul 13, 2018 | 1169 | Ex. 1169D - Insulin Product Sales Download | |
| Jul 13, 2018 | 1123 | B. Farhadieh, ¿¿¿Determination of CMC and Partial Specific Volume of Polysorbates 20, 60 and 80 from Densities of Their Aqueous Solutions¿¿¿, J. of Pharma. Sciences, Vol. 62, No. 10, pp.1685-1688 (Oct. 1973) Download | |
| Jul 13, 2018 | 1108 | SG Cowen ¿¿¿ Perspectives, Pharmaceutical Therapeutic Categories Outlook , pp. 134-148 (Oct. 2001) Download | |
| Jul 13, 2018 | 1102 | UBS Equities ¿¿¿ Sanofi-Aventis Q105, May 13, 2005 Download | |
| Jul 13, 2018 | 1099 | UBS Equities ¿¿¿ Sanofi-Aventis Q405, Jan. 24, 2006 Download | |
| Jul 13, 2018 | 1090 | DiMasietal, et al. ¿¿¿Innovation in the Pharmaceutical Industry: New Estimates of R&D Costs¿¿¿, J. of Health Eco., 37 (2016) pp. 20-33 Download | |
| Jul 13, 2018 | 1137 | LANGER, Robert S. et al. U.S. Publication No. 2015/0320837, Nov. 12, 2015 Download | |
| Jul 13, 2018 | 1098 | WebMD ¿¿¿ ¿¿¿Types of Insulin for Diabetes Treatment¿¿¿ (accessed May 3, 2018) Download | |
| Jul 13, 2018 | 1114 | Neuprogen¿¿ (Filgratim), Amgen Inc. Product label, April 2, 1998 Download | |
| Jul 13, 2018 | 1164 | U.S. Patent No. 4,849,227 (¿¿¿Cho¿¿¿) Download | |
| Jul 13, 2018 | 1091 | David et al., ¿¿¿Commercial Success Economic Principles Applied to Patent Litigation¿¿¿, Economics of Pat. Damages, Chap. 9, pp. 159-160 Download | |
| Jul 13, 2018 | 1093 | CDC, ¿¿¿Long-Term Trends in Diabetes¿¿¿, April 2017, (http://www.cdc.gov/biabetes/data) Download | |
| Jul 13, 2018 | 1115 | Nielsen, et al., ¿¿¿Effect of Environmental Factors On the Kinetics of Insulin Fibril Formation: Elucidation of the Molecular Mechanism¿¿¿, Biochemistry 2001, 40, pp. 6036-6046 (2001) Download | |
| Jul 13, 2018 | 1100 | UBS Equities ¿¿¿ Sanofi-Aventis Q305, Nov. 3, 2005 Download | |
| Jul 13, 2018 | 1181 | Declaration of Professor Samuel H. Yalkowsky Download | |
| Jul 13, 2018 | 1132 | Part 2 - A. Martin, et al., ¿¿¿Physical Principles In the Pharmaceutical Sciences¿¿¿ Phys. Pharmacy, Drug Dynamics Inst., Col. Of Pharma., Univ. of Texas, 1983 Download | |
| Jul 13, 2018 | 1088 | FDA ¿¿¿ 27th Orange Book (2007) Download | |
| Jul 13, 2018 | 1141 | 2001 PDR Entry fro ¿¿¿Norditropin¿¿¿¿¿, p. 2236 Download | |
| Jul 13, 2018 | 1173 | Susan Budavari et al., The Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals (12th ed. 1996) Download | |
| Jul 13, 2018 | 1126 | EP 1019022 B1 (¿¿¿EP ¿¿¿022¿¿¿) Download | |
| Jul 13, 2018 | 1120 | Hawley¿¿¿s Condensed Chemical Dictionary, 12th Ed. ¿¿¿ Strong acid reference¿¿¿, pp. 890-891 (1993) Download | |
| Jul 13, 2018 | 1138 | LANGER, Robert S. et al. U.S. Patent No. 9,994,615 B2, Jun. 12, 2018 Download | |
| Jul 13, 2018 | 1096 | U.S. SEC Form 20-F for Sanofi-Aventis FY 2002 Download | |
| Jul 13, 2018 | 1134 | 1997 PDR Entry for ¿¿¿Humalog¿¿¿¿¿, pp. 1488-1490 Download | |
| Jul 13, 2018 | 1103 | St. Louis Federal Reserve Economic Data, Consumer Price Index for All Urban Consumers¿¿¿ CPI Monthly (accessed May 24, 2018) Download | |
| Jul 13, 2018 | 1107 | SG Cowen ¿¿¿ Perspectives, Pharmaceutical Therapeutic Categories Outlook, pp. 136-156 (March 2002) Download | |
| Jul 13, 2018 | 1168 | Z. Strickley, ¿¿¿Stability of Human Insulin Effect of Water Content and Added Excipients on the Degradation of Lyophilized Insulin at Acidic pH¿¿¿, Thesis, Dept. of Pharm. and Pharmaceutical Chem. , U. of Utah, Dec. 1995 Download | |
| Jul 13, 2018 | 1068 | Q2 2005 Sanofi-Aventis Earnings Conference Call Download | |
| Jul 13, 2018 | 1058 | Affidavit of Marlene S. Bobka (July 3, 2018) Download | |
| Jul 13, 2018 | 1064 | U.S. SEC Form 20-F for Sanofi-Aventis FY 2005 - Part 2 Download | |
| Jul 13, 2018 | 1074 | LANTUS¿¿ Using Lantus ¿¿¿How to Use the Lantus¿¿ SoloSTAR¿¿ Pen¿¿¿ (Current) Download | |
| Jul 13, 2018 | 1066 | Q4 2005 Sanofi-Aventis Earnings Conference Call Download | |
| Jul 13, 2018 | 1057 | Affidavit of Marlene S. Bobka (July 3, 2018) Download | |
| Jul 13, 2018 | 1056 | Campbell, Kevin; ¿¿¿Insulin Costs Are Skyrocketing. This is Why.¿¿¿, U.S. News and World Report, June 29, 2018, pp.1-3 Download | |
| Jul 13, 2018 | 1076 | LANTUS¿¿ Resources (Current) Download | |
| Jul 13, 2018 | 1079 | LANTUS¿¿ Home Page (Current) Download | |
| Jul 13, 2018 | 1064 | U.S. SEC Form 20-F for Sanofi-Aventis FY 2005 - Part 2 Download | |
| Jul 13, 2018 | 1060 | Sanofi Press Release, ¿¿¿Prospective Study Published in Diabetes Care Confirms Basal Therapy with LANTUS¿¿ Improves Glycemic Control In Patients with Type 2 Diabetes Poorly Controlled on Prior Insulin Regimens¿¿¿ (June 8, 2005) Download | |
| Jul 13, 2018 | 1078 | LANTUS¿¿ Support ¿¿¿LANTUS¿¿ Tips and Support¿¿¿ (October 2006) Download | |
| Jul 13, 2018 | 1051 | EP Pub. 0368187 A2 Download | |
| Jul 13, 2018 | 1057 | Affidavit of Marlene S. Bobka (July 3, 2018) Download | |
| Jul 13, 2018 | 1069 | Q1 2005 Sanofi-Aventis Earnings Conference Call Download | |
| Jul 13, 2018 | 1070 | LANTUS¿¿ (NDA 21-081 S-024) ¿¿¿ Labeling-Container Carton Labels, Labeling-Package Insert, Rev. Mar. 2007 Download | |
| Jul 13, 2018 | 1075 | LANTUS¿¿ Savings Card (Current) Download | |
| Jul 13, 2018 | 1073 | LANTUS¿¿ Why Lantus Page ¿¿¿ Ask Your Healthcare Provider About Switching to LANTUS¿¿¿¿¿ (October 16, 2006) Download | |
| Jul 13, 2018 | 1063 | U.S. SEC Form 20-F for Sanofi-Aventis FY 2006 Download | |
| Jul 13, 2018 | 1072 | Mestre-Ferrandiz, et al., ¿¿¿The R&D Cost of a New Medicine¿¿¿, Office of Health Economics, pp. 1-100 (Dec. 2012) Download | |
| Jul 13, 2018 | 1065 | U.S. SEC Form 20-F for Sanofi-Aventis FY 2004 - Part 2 Download | |
| Jul 13, 2018 | 1053 | Center for Drug Evaluation and Research, Approval for ¿¿¿NUTROPIN AQ¿¿¿ (App. 20-522/S-10), Apr. 10, 2000 Download | |
| Jul 13, 2018 | 1052 | Amgen, Inc. profile of ¿¿¿NEUPOGEN¿¿¿ (Filgrastim), Apr. 2, 1998, pp. 1-27pp. 1-27 Download | |
| Jul 13, 2018 | 1055 | Deposition of Dr. Laurence Baker, Ph.D. (June 22, 2018) Download | |
| Jul 13, 2018 | 1061 | Sanofi Press Release, ¿¿¿LANTUS¿¿ Add-on to Oral Monotherapy Therapy Showed Improved Glycemic Control in Type 2 Diabetes Patients Compared to oral Actos Add-on to Oral Therapy¿¿¿ (June 13, 2005) Download | |
| Jul 13, 2018 | 1054 | Deposition of Dr. Berhard Trout (June 21, 2018) Download | |
| Jul 13, 2018 | 1077 | LANTUS¿¿ New to Lantus Page (October 2006) Download | |
| Jul 13, 2018 | 1062 | Sanofi Press Release, ¿¿¿Data Presented at ADA Showed That Basal Insulin Therapy with LANTUS¿¿ Achieved Target Glycemic Control In Poorly Controlled Type 2 Diabetes¿¿¿ (June 13, 2005) Download | |
| Jul 13, 2018 | 1071 | NDA 21-081 S-005 ¿¿¿ Efficacy-New Dosing Regimen ¿¿¿ Label, Apr. 30, 2003 Download | |
| Jul 13, 2018 | 1058 | Affidavit of Marlene S. Bobka (July 3, 2018) Download | |
| Jul 13, 2018 | 1067 | Q3 2005 Sanofi-Aventis Earnings Conference Call Download | |
| Jul 13, 2018 | 1065 | U.S. SEC Form 20-F for Sanofi-Aventis FY 2004 - Part 2 Download | |
| Jul 13, 2018 | 1057 | Download | |
| Jul 13, 2018 | 1058 | Download | |
| Jul 13, 2018 | 1064 | U.S. SEC Form 20-F for Sanofi-Aventis FY 2005 - part 1 Download | |
| Jul 13, 2018 | 1065 | U.S. SEC Form 20-F for Sanofi-Aventis FY 2004 - Part 1 Download | |
| Jul 13, 2018 | 1111 | Ex. 1111B - References Considered by Professor Robert Langer Download | |
| Jul 13, 2018 | 1124 | Download | |
| Jul 13, 2018 | 1132 | Download | |
| Jul 13, 2018 | 1169 | Ex. 1169F - Lantus Market Shares Download | |
| Jul 13, 2018 | 1169 | Ex. 1169B - Revenues by Product Download | |
| Jul 13, 2018 | 1169 | Ex. 1169E - Lantus Prescriptions Download | |
| Jul 13, 2018 | 1169 | Ex. 1169C - Diabetes Patient Population Download | |
| Jul 13, 2018 | 1169 | Ex. 1169A - Curriculum Vitae of DeForest McDuff Download | |
| Jul 13, 2018 | 1169 | Declaration of DeForest McDuff Download | |
| Jul 13, 2018 | 1174 | 1174A- Curriculum Vitae of William Curtis Biggs Download | |
| Jul 13, 2018 | 1183 | References Considered by Professor Robert Langer Download | |
| Jul 11, 2018 | 40 | Mylan Pharmaceutical Inc.'s Updated Exhibit List Download | |
| Jul 11, 2018 | 1059 | Transcript of Telephone Conference Held July 5, 2018 in IPR2017-01526 and IPR2017-01528 Download | |
| Jun 13, 2018 | 39 | Mylan Pharmaceuticals Inc. Revised Power of Attorney Download | |
| Jun 13, 2018 | 38 | Mylan Pharmaceuticals Inc. Updated Mandatory Notices Download | |
| Jun 6, 2018 | 37 | Granting Petitioner's Unopposed Motions for Pro Hac Vice Recognition Download | |
| May 29, 2018 | 36 | Mylan Pharmaceutical's Unopposed Motion for Pro Hac Vice Recognition Download | |
| May 29, 2018 | 35 | Notice of Deposition of Dr. Laurence baker Download | |
| May 29, 2018 | 33 | Joint Stipulation to Modify the Scheduling Order Download | |
| May 29, 2018 | 34 | Notice Of Deposition of Dr. Bernhardt Trout Download | |
| May 29, 2018 | 1049 | Biography of Elham Firouzi Steiner Download | |
| May 29, 2018 | 1048 | Declaration of ElhamSteiner Download | |
| May 8, 2018 | 32 | Supplemental Power of Attorney for Patent Owner Sanofi-Aventis Deutschland GmbH Download | |
| May 8, 2018 | 31 | Patent Owner's Updated Mandatory Notices Pursuant to 37 C.F.R. 42.8 Download | |
| May 3, 2018 | 30 | Order Granting Patent Owner's Pro Hac Vice Motions to Admit Robert Vlasis Download | |
| Apr 18, 2018 | 2049 | Declaration of Robert Vlasis Download | |
| Apr 18, 2018 | 2050 | Biography of Robert Vlasis Download | |
| Apr 18, 2018 | 29 | Motion for Pro Hac Vice Admission Under 37 C.F.R. 42.10 Download | |
| Apr 3, 2018 | 28 | Mylan Pharmaceutical's Objections Download | |
| Mar 27, 2018 | 2036 | Ratner et al., Persistent Cutaneous Insulin Allergy, Diabetes (1990) Download | |
| Mar 27, 2018 | 2023 | Brange et al., Chemical Stability of Insulin. 2, Pharm. Res. (1992) Download | |
| Mar 27, 2018 | 2035 | Moore & Leppert, Role of Aggregated Human Growth-Hormone (hGH) (1980) Download | |
| Mar 27, 2018 | 2021 | Kreilgaard et al., Effects of Additives on the Stability, Pharm. Sci. (1999) Download | |
| Mar 27, 2018 | 2026 | Fisher & Porter, Stability of Bovine Insulin, J. Pharm. Pharmacol (1981) Download | |
| Mar 27, 2018 | 2009 | Campbell et al., Insulin glargine, Clinical Therapeutics (December 2001) Download | |
| Mar 27, 2018 | 2040 | Curriculum Vitae of Dr. Laurence C. Baker Download | |
| Mar 27, 2018 | 2016 | Banga, Therapeutic Peptides and Proteins: Formulation, Processing, and Delivery Systems (1995) Download | |
| Mar 27, 2018 | 2022 | Darrington, Effects of Insulin Concentration, Pharm. Res. (1995) Download | |
| Mar 27, 2018 | 2027 | Ingram, Gene Mutations in Human Hemoglobin, Nature (Aug. 17, 1957) Download | |
| Mar 27, 2018 | 2015 | Rosskamp & Park, Long-acting Insulin Analogs, Diabetes Care (March 1999) Download | |
| Mar 27, 2018 | 2048 | U.S. Price per Insulin Unit of Long-Acting Insulin Products Download | |
| Mar 27, 2018 | 2008 | March 12, 2018, Deposition Transcript of Dr. Samuel H. Yalkowsky Download | |
| Mar 27, 2018 | 2010 | FDA¿¿¿s Office of Clinical Pharmacology and Biopharmaceutics Review 2005 Download | |
| Mar 27, 2018 | 2019 | Nelson & Cox, Lehninger Principles of Biochemistry (3rd ed. 2000) (2 of 2) Download | |
| Mar 27, 2018 | 2041 | Dr. Laurence C. Baker¿¿¿s Prior Testimony Download | |
| Mar 27, 2018 | 2042 | Dr. Laurence C. Baker¿¿¿s Documents Relied On Download | |
| Mar 27, 2018 | 2030 | 2001 Physician¿¿¿s Desk Reference (Drugs) Download | |
| Mar 27, 2018 | 2046 | U.S. Formulary Placement of Long-Acting Insulin Products Download | |
| Mar 27, 2018 | 27 | Patent Owner's Response to Petition for Inter Partes Review of U.S. Patent No. 7,476,652 Download | |
| Mar 27, 2018 | 2017 | Jaeger et al., Peroxide Accumulation, J. Biochem. & Biophys. Methods (1994) Download | |
| Mar 27, 2018 | 2044 | U.S. Share of Lantus Vial Among Long-Acting Injectable Insulin Products Download | |
| Mar 27, 2018 | 2033 | Pisano & Kostenbauder, Interaction of Preservatives with Macromolecules II (1957) Download | |
| Mar 27, 2018 | 2032 | Patel & Foss, Interaction of Some Pharmaceuticals with Macromolecules I (1964) Download | |
| Mar 27, 2018 | 2007 | Curriculum Vitae of Dr. Bernhardt Trout Download | |
| Mar 27, 2018 | 2011 | Brange et al., Chemical Stability of Insulin 1, Pharm. Res. (1992) Download | |
| Mar 27, 2018 | 2013 | Clodfelter et al., Effects of Non-Covalent Self-Association, Pharm. Res. (1998) Download | |
| Mar 27, 2018 | 2024 | Maislos, The Source of the Circulating Aggregate of Insulin, J. Clin. Invest. (1986) Download | |
| Mar 27, 2018 | 2037 | Dische, et al., Insulin as an Amyloid-Fibril Protein, Diabetologia (1988) Download | |
| Mar 27, 2018 | 2006 | Declaration of Dr. Bernhardt Trout Download | |
| Mar 27, 2018 | 2020 | Wang, Instability, Stabilization, and Formulation, Int¿¿¿l J. Pharm. (1999) Download | |
| Mar 27, 2018 | 2012 | Sluzky et al., Kinetics of Insulin Aggregation, Proc. Natl. Acad. Sci. (1991) Download | |
| Mar 27, 2018 | 2028 | Owens et al., ¿¿¿Insulins Today and Beyond,¿¿¿ The Lancet (September 1, 2001) Download | |
| Mar 27, 2018 | 2029 | Roberts & Urey, The Mechanisms of Acid, J. Am. Chem. Soc. (1939) Download | |
| Mar 27, 2018 | 2043 | U.S. Dollar Sales of Long-Acting Insulin Products Download | |
| Mar 27, 2018 | 2047 | U.S. Total Marketing Expenditures of Long-Acting Insulin Products Download | |
| Mar 27, 2018 | 2019 | Nelson & Cox, Lehninger Principles of Biochemistry (3rd ed. 2000) (2 of 2) Download | |
| Mar 27, 2018 | 2038 | Summary of Claim Constructions from Related Cases Download | |
| Mar 27, 2018 | 2014 | Techniques of Solubilization of Drugs 15-89 (Samuel H. Yalkowsky ed., 1981) Download | |
| Mar 27, 2018 | 2045 | U.S. Total Prescriptions of Long-Acting Insulin Products Download | |
| Mar 27, 2018 | 2018 | Hoogwerf, Advances in the Treatment of Diabetes Mellitus in the Elderly (1996) Download | |
| Mar 27, 2018 | 2039 | Dr. Laurence C. Baker¿¿¿s Declaration Download | |
| Mar 27, 2018 | 2034 | Donbrow et al., Autoxidation of Polysorbates (December 1978) Download | |
| Mar 27, 2018 | 2025 | 2001 Physician¿¿¿s Desk Reference (Insulin) Download | |
| Mar 27, 2018 | 2005 | Canadian Patent No. 1,258,427 Download | |
| Mar 27, 2018 | 2031 | Fife & Pujari, Metal Ion Catalysis, Bioorganic Chem. (2000) Download | |
| Mar 27, 2018 | 2019 | Nelson & Cox, Lehninger Principles of Biochemistry (3rd ed. 2000) (1 of 2) Download | |
| Feb 28, 2018 | 25 | Patent Owner's Notice of Deposition of Dr. Samuel H. Yalkowsky Download | |
| Feb 28, 2018 | 26 | Patent Owner's Objections to Admissibility of Supplemental Evidence Served by Petitioner Mylan Pharmaceutical Inc. in Inter Partes Review Download | |
| Feb 21, 2018 | 22 | Order Conduct of the Proceeding Extending Due Date 1 and Due Date 2 of the Scheduling Order Download | |
| Feb 21, 2018 | 24 | Mylan Pharmaceuticals's Updated Exhibit List Download | |
| Feb 21, 2018 | 23 | Order Granting-in-part and Denying-in-part Petitioner's Motion for Supplemental Information Download | |
| Feb 21, 2018 | 1036 | Affidavit of Christopher Butler (April 4, 2017) Download | |
| Feb 21, 2018 | 1037 | Aventispharma-us.com, Lantus Prescribing Information (Jan. 10, 2001) Download | |
| Feb 5, 2018 | 21 | Patent Owner's Opposition to Petitioner's Motion for Supplemental Information Download | |
| Jan 29, 2018 | 19 | Mylan Pharmaceuticals Motion For Supplemental Information Download | |
| Jan 29, 2018 | 20 | Mylan Pharmaceutical's Updated Exhibit List Download | |
| Jan 29, 2018 | 1046 | Exhibit 1046 - Board Email Download | |
| Jan 29, 2018 | 1047 | Exhibit 1047 Download | |
| Jan 26, 2018 | 18 | Mylan Pharmaceutical's Updated Exhibit List Download | |
| Dec 28, 2017 | 17 | Mylan's Objecjections Download | |
| Dec 28, 2017 | 16 | Patent Owner's Objections to Admissibility of Evidence Served with Petitioner Mylan Pharmaceutical Inc.'s Petition for Inter Partes Review Download | |
| Dec 15, 2017 | 15 | SCHEDULING ORDER 37 C.F.R. ¿¿ 42.5(a) Download | |
| Dec 14, 2017 | 14 | PETITIONER MYLAN PHARMACEUTICALS INC.'S MANDATORY CHANGE-OF-INFORMATION NOTICES Download | |
| Dec 13, 2017 | 13 | Trial Instituted Document Download | |
| Dec 12, 2017 | 12 | PETITIONER MYLAN PHARMACEUTICALS INC.'S MANDATORY CHANGE-OF-INFORMATION NOTICES Download | |
| Oct 11, 2017 | 11 | Declaration of Clark Lin Download | |
| Oct 11, 2017 | 10 | Mylan Pharmaceuticals Inc.'s Updated Exhibit List Download | |
| Oct 11, 2017 | 1004 | Corrected Exhibit 1004 Download | |
| Oct 6, 2017 | 9 | Conduct of the Proceeding 37 C.F.R ¿¿ 42.5 Download | |
| Sep 14, 2017 | 8 | Preliminary Response to Petition for Inter Partes Review of U.S. Patent No. 7,476,652 Download | |
| Sep 14, 2017 | 2004 | U.S. Patent No. 5,656,722 Download | |
| Sep 14, 2017 | 2002 | Formulation-Related Problems Associated with Intravenous Drug Delivery Download | |
| Sep 14, 2017 | 2001 | 2001 Physicians Desk Reference (PDR) Download | |
| Sep 14, 2017 | 2003 | Physical Biochemistry of Protein Drugs, in Protein and Peptide Delivery Download | |
| Aug 24, 2017 | 7 | Patent Owner's Updated Mandatory Notices Download | |
| Jun 20, 2017 | 5 | Patent Owner's Power of Attorney Download | |
| Jun 20, 2017 | 6 | Patent Owner's Mandatory Notice Download | |
| Jun 20, 2017 | 6 | Patent Owner's Mandatory Notice Download | |
| Jun 20, 2017 | 4 | Patent Owner's Mandatory Notices Download | |
| Jun 15, 2017 | 3 | Notice of Accord Filing Date Download | |
| Jun 5, 2017 | 2 | PETITION FOR INTER PARTES REVIEW U.S. PATENT NO. 7,476,652 Download | |
| Jun 5, 2017 | 1031 | R. Jones, Insulin Glargine Aventis Pharma, IDrugs 3:1081-87 (2000) Download | |
| Jun 5, 2017 | 1012 | U. Derewenda et al. Phenol Stabilizes More Helix in a New Symmetrical Zinc Insulin Hexamer, Nature 338:594-6 (April 1989) Download | |
| Jun 5, 2017 | 1018 | W.D. Lougheed et al., Insulin Aggregation in Artificial Delivery Systems, Diabetologia 19:1-9 (July 1980) Download | |
| Jun 5, 2017 | 1007 | 1007A - Certified English translation for Ex. 1007 (FASS Entry for INSUMAN INFUSAT) Download | |
| Jun 5, 2017 | 1001 | 1001A Part III - FH US 7476652 Download | |
| Jun 5, 2017 | 1022 | M. Katakam et al., Effect of Surfactants on the Physical Stability of Recombinant Human Growth Hormone, J. Pharm. Sci. 84:713-16 (June 1995) Download | |
| Jun 5, 2017 | 1010 | FDA Drug Approval for LANTUS (NDA 02-1081) (April 20, 2000) Download | |
| Jun 5, 2017 | 1015 | J. Brange et al., Toward Understanding Insulin Fibrillation, J. Pharm. Sci. 86:517-25 (May 1997) Download | |
| Jun 5, 2017 | 1001 | 1001A Part III - FH US 7476652 Download | |
| Jun 5, 2017 | 1024 | U.S. Patent No. 4,839,341 Stabilized Insulin Formulations (Issued June 13, 1989) Download | |
| Jun 5, 2017 | 1017 | K. Hallas-Moller, The Lente Insulins, Diabetes 5:7-14 (1956) Download | |
| Jun 5, 2017 | 1029 | M. Heile and D. Schneider, The Evolution of Insulin Therapy in Diabetes Mellitus, J. Fam. Pract. 61 (5 Suppl.: S6-12 (May 2012) Download | |
| Jun 5, 2017 | 1001 | 1001A Part III - FH US 7476652 Download | |
| Jun 5, 2017 | 1013 | H. Berchtold and R. Hilgenfeld, Binding of Phenol to R6 Insulin Hexamers, Biopolymers 51:165-72 (1999) Download | |
| Jun 5, 2017 | 1003 | 1003A - Curriculum Vitae of Professor Samuel H. Yalkowsky Download | |
| Jun 5, 2017 | 1007 | 1007A - Certified English translation for Ex. 1007 (FASS Entry for INSUMAN INFUSAT) Download | |
| Jun 5, 2017 | 1009 | EMEA Public Statement on INSUMAN INFUSAT (February 14, 2000) Download | |
| Jun 5, 2017 | 1001 | 1001A Part III - FH US 7476652 Download | |
| Jun 5, 2017 | 1001 | 1001A Part III - FH US 7476652 Download | |
| Jun 5, 2017 | 1033 | 1033B - Declaration of Hans-Peter Krieger (Deutsche National Bibliothek Librarian) for receipt of 2001 Rote Liste by Deutsche National Bibliothek on February 16, 2001 Download | |
| Jun 5, 2017 | 1011 | P. Gillies et al., Insulin Glargine, Drugs 59:253-60 (February 2000) Download | |
| Jun 5, 2017 | 1006 | W.D. Lougheed et al., Physical Stability of Insulin Formulations, Diabetes 32:424-32 (May 1983) Download | |
| Jun 5, 2017 | 1035 | 2004 CNN Money article regarding Aventis Pharma merger with Sanofi-Synthelabo to create Sanofi-Aventis, the parent corporation of '930 patent assignee Sanofi-Aventis Deutschland GmbH Download | |
| Jun 5, 2017 | 1005 | D.R. Owens et al., Pharmacokinetics of 125I-Labeled Insulin Glargine (HOE 901) in Healthy Men, Diabetes Care 23:813-19 (June 2000) Download | |
| Jun 5, 2017 | 1001 | 1001A Part III - FH US 7476652 Download | |
| Jun 5, 2017 | 1033 | 1033B - Declaration of Hans-Peter Krieger (Deutsche National Bibliothek Librarian) for receipt of 2001 Rote Liste by Deutsche National Bibliothek on February 16, 2001 Download | |
| Jun 5, 2017 | 1019 | Excerpts from Handbook of Pharmaceutical Excipients 2nd Edition (eds. A. Wade and P.J. Weller) (American Pharmaceutical Association, Washington) (The Pharmaceutical Press, London) (1994) Download | |
| Jun 5, 2017 | 1002 | 1002A - FH US 7713930 Download | |
| Jun 5, 2017 | 1001 | 1001A Part III - FH US 7476652 Download | |
| Jun 5, 2017 | 1008 | U. Grau and C.D. Saudek, Stable Insulin Preparation for Implanted Insulin Pumps, Diabetes 36:1453-59 (December 1987) Download | |
| Jun 5, 2017 | 1003 | 1003A - Curriculum Vitae of Professor Samuel H. Yalkowsky Download | |
| Jun 5, 2017 | 1001 | 1001A Part III - FH US 7476652 Download | |
| Jun 5, 2017 | 1003 | 1003A - Curriculum Vitae of Professor Samuel H. Yalkowsky Download | |
| Jun 5, 2017 | 1001 | 1001A Part III - FH US 7476652 Download | |
| Jun 5, 2017 | 1002 | 1002A - FH US 7713930 Download | |
| Jun 5, 2017 | 1016 | L.S. Jones et al., Surfactant-Stabilized Protein Formulations: A Review of Protein-Surfactant Interactions and Novel Analytical Methodologies, in THERAPEUTIC PROTEIN AND PEPTIDE FORMULATION AND DELIVERY, ACS SYMPOSIUM SERIES Download | |
| Jun 5, 2017 | 1032 | I.R. Schmolka, Poloxamers in the Pharmaceutical Industry, in POLYMERS FOR CONTROLLED DRUG DELIVERY, CHAPTER 10 (CRC Press) (1991) Download | |
| Jun 5, 2017 | 1014 | J. Brange and L. Langkjaer, Insulin Structure and Stability, in STABILITY AND CHARACTERIZATION OF PROTEIN AND PEPTIDE DRUGS, CASE HISTORIES CHAPTER 11, 315-50 Download | |
| Jun 5, 2017 | 1034 | L. Gatlin and C. Gatlin, Minimizing Injection Pain & Damage in INJECTABLE DRUG DEVELOPMENT TECHNIQUES TO REDUCE PAIN AND IRRITATION CHAPTER 17 Download | |
| Jun 5, 2017 | 1026 | A. Chawla et al. Aggregation of Insulin, Containing Surfactants, in Contact with Different Materials, Diabetes 34:420-24 (May 1985) Download | |
| Jun 5, 2017 | 1027 | Y-C Lee et al., Effect of Brij-78 on Systemic Delivery of Insulin from an Ocular Device J. Pharm. Sci. 86:430-33 (April 1997) Download | |
| Jun 5, 2017 | 1023 | U.S. Patent No. 4,153,689 Stable Iinsulin Preparation for Nasal Administration (Issued May 8, 1979) Download | |
| Jun 5, 2017 | 1007 | 1007A - Certified English translation for Ex. 1007 (FASS Entry for INSUMAN INFUSAT) Download | |
| Jun 5, 2017 | 1020 | W.R. Ashford and S. Landi, Stabilizing Properties of Tween 80 in Dilute Protein Solutions, Bull. Parenteral Drug Assoc. 20:74-81 (1966) Download | |
| Jun 5, 2017 | 1001 | 1001A Part III - FH US 7476652 Download | |
| Jun 5, 2017 | 1003 | 1003A - Curriculum Vitae of Professor Samuel H. Yalkowsky Download | |
| Jun 5, 2017 | 1004 | 1004A - Notarized Affidavit Lloyd Library Download | |
| Jun 5, 2017 | 1028 | Y-C Lee et al., Review on the Systemic Delivery of Insulin via the Ocular Route, International J. Pharmaceutics 233:1-18 (February 2002) Download | |
| Jun 5, 2017 | 1 | Power of Attorney Download | |
| Jun 5, 2017 | 1030 | ADIS R&D Profile Insulin Glargine: Glargine, HOE 71GT15, HOE 71GT80, HOE 901, Drugs R&D 2:107-09 (August 1999) Download | |
| Jun 5, 2017 | 1001 | 1001A Part III - FH US 7476652 Download | |
| Jun 5, 2017 | 1021 | H. Thurow and K. Geisen, Stabilisation of Dissolved Proteins Against Denaturation at Hydrophobic Interfaces, Diabetologia 27:212-18 (1984) Download | |
| Jun 5, 2017 | 1025 | E.P. Publication No. 0200383 An Improved Method for Administering Insulin (Issued November 5, 1986) Download | |
| Jun 5, 2017 | 1004 | 1004A - Notarized Affidavit Lloyd Library Download | |
| Jun 5, 2017 | 1033 | 1033B - Declaration of Hans-Peter Krieger (Deutsche National Bibliothek Librarian) for receipt of 2001 Rote Liste by Deutsche National Bibliothek on February 16, 2001 Download | |
| Jun 5, 2017 | 1003 | 1003A - Curriculum Vitae of Professor Samuel H. Yalkowsky Download | |
| Jun 5, 2017 | 1001 | 1001A Part III - FH US 7476652 Download | |
| Jun 5, 2017 | 1004 | 1004A - Notarized Affidavit Lloyd Library Download | |
| Jun 5, 2017 | 1001 | 1001A Part IV - FH US 7476652 Download | |
| Jun 5, 2017 | 1001 | 1001A Part II - FH US 7476652 Download | |
| Jun 5, 2017 | 1001 | 1001A Part V - FH US 7476652 Download | |
| Jun 5, 2017 | 1001 | 1001A Part VI - FH US 7476652 Download | |
| Jun 5, 2017 | 1001 | U.S. Patent No. 7,476,652 Download | |
| Jun 5, 2017 | 1001 | 1001A Part I - FH US 7476652 Download | |
| Jun 5, 2017 | 1002 | U.S. Patent No. 7,713,930 Download | |
| Jun 5, 2017 | 1003 | 1003B - Materials Reviewed by Professor Samuel H. Yalkowsky Download | |
| Jun 5, 2017 | 1003 | Expert Declaration of Professor Samuel H. Yalkowsky in Support of Petition for Inter Partes Review of Patent No. 7,476,652 and U.S. Patent No. 7,713,930 Download | |
| Jun 5, 2017 | 1004 | Physicians Desk Reference Download | |
| Jun 5, 2017 | 1007 | 2000 FASS Entry for INSUMAN INFUSAT (January 2000) Download | |
| Jun 5, 2017 | 1033 | 1033A -Certified Translation of Exh. 1033 (2001 Rote Liste; Entry for INISUMAN INFUSAT) Download | |
| Jun 5, 2017 | 1033 | 2001 Rote Liste; Entry for INSUMAN INFUSAT Download |
